<DOC>
	<DOCNO>NCT00305487</DOCNO>
	<brief_summary>The aim study determine efficacy safety ciclesonide nasal spray child seasonal allergic rhinitis . Ciclesonide administer intranasally two dose level daily . The study consist baseline period ( 1 3 week ) treatment period ( 2 week ) .</brief_summary>
	<brief_title>Safety Efficacy Ciclesonide Pediatric Patients ( 6 11 Years Age ) With Seasonal Allergic Rhinitis ( BY9010/M1-417 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Main Written inform consent General good health seasonal allergic rhinitis Positive standard skin prick test Main Pregnancy , nursing , plan become pregnant donate gamete vitro fertilization Participation investigational drug trial within 30 day precede Screening Visit A known hypersensitivity corticosteroid ingredient study drug formulation Plans travel outside study area ( know pollen area investigative site ) 24 hour final 7 day baseline period Plans travel outside study area ( know pollen area investigative site ) 2 consecutive day OR 3 day total treatment period Use prohibit concomitant medication Nonvaccinated exposure active infection chickenpox measles within 21 day precede Screening Visit Use antiepileptic drug epilepsy within 30 day Screening Visit Study participation one patient household</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hay Fever</keyword>
	<keyword>Seasonal Allergic Rhinitis</keyword>
	<keyword>Nasal spray</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>Allergic Rhinitis</keyword>
</DOC>